Good morning, and welcome to Charles River Laboratories third quarter 2024 ... driven primarily by demand for our Endosafe testing consumables as well as improving instrument placements.

In Pfizer Sale #140 (Sandwich, UK) Sale Featuring... This auction is live! You need to be registered and approved to bid at this auction. Watch the auction as a guest You have been outbid. For the ...

Charles River Laboratories, a Wilmington, Mass., pharma services giant, is closing a Skokie office that will result in the ...

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...

In a report released yesterday, Charles Rhyee from TD Cowen maintained a Hold rating on Charles River Labs (CRL – Research Report), with ...

In a report released on November 7, Patrick B Donnelly from Citi maintained a Sell rating on Charles River Labs (CRL – Research Report).

Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter earnings of $69.7 million. On a per-share ...

Charles River Laboratories Intl ( (CRL)) has released its Q3 earnings. Here is a breakdown of the information Charles River Laboratories Intl presented to its investors. Charles River Laboratories ...

Inside a large but nondescript building near the Longfellow Bridge on the Cambridge side of the Charles River is what’s essentially a jet engine. “If you look up, you’ll get a sense of the size,” said ...

NJ Bio, Inc. and Charles River Laboratories, Inc. have announced a strategic alliance to offer complementary services to clients including early development and optimization to manufacturing of ...

FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based therapies for chronic diseases. The agreement will involve the ...

Have you evaluated the performance of Charles River Laboratories' (CRL) international operations for the quarter ending September 2024? Given the extensive global presence of this medical research ...